Magnus Ingelman-Sundberg

Awards Nomination 20+ Million Readerbase

Google Scholar citation report

Citations : 613

Journal of Pharmacogenomics & Pharmacoproteomics received 613 citations as per Google Scholar report

Journal of Pharmacogenomics & Pharmacoproteomics peer review process verified at publons

25+ Million Website Visitors

Indexed In

Open J Gate
Genamics JournalSeek
Academic Keys
JournalTOCs
ResearchBible
Electronic Journals Library
RefSeek
Hamdard University
EBSCO A-Z
OCLC- WorldCat
Proquest Summons
SWB online catalog
Virtual Library of Biology (vifabio)
Publons
MIAR
Euro Pub
Google Scholar

Useful Links

Share This Page

Journal Flyer

Open Access Journals

Magnus Ingelman-Sundberg

Magnus Ingelman-Sundberg

Magnus Ingelman-Sundberg Professor, Section Head and Vice Chairman Molecular Toxicology Karolinska Institutet Sweden

Biography

Professor of Molecular Toxicology at Karolinska Institutet, Sweden, since 1996. More than 410 original papers, 29 000 citations and an h-factor of 90 (Google Scholar). Member of The Nobel Assembly at Karolinska Institutet since 2008 and member of Faculty of 1000 Biology since 2006. Ranked as the 3rd most highly impact researcher of 4,000 in the field of drug metabolism (www.cytochrome.net ) and one of the worlds most cited authors within the category Pharmacology http://isihighlycited.com/. Active in the research fields of pharmacogenomics, epigenetics and drug induced liver injury.

Research Interest

Pharmacogenomics Epigenetics Drug induced liver injury